QMS Medical reports FY26 revenue of INR172.9 crores
QMS Medical Allied Services released the transcript for its FY26 earnings call, reporting an 11% rise in revenue to INR172.9 crores. EBITDA stood at INR25.9 crores with a PAT of INR11.9 crores. The product segment contributed 69% of revenue, while services contributed 31%, supported by 32,380 healthcare camps.

*this image is generated using AI for illustrative purposes only.
QMS Medical Allied Services Limited has released the transcript of its earnings call for the half year and year ended March 31, 2026. The company reported an 11% year-on-year growth in revenue from operations, which reached INR172.9 crores for FY26. EBITDA stood at INR25.9 crores, while profit after tax was INR11.9 crores. The financial results were approved by the Board on May 30, 2026, and the disclosure was submitted to the National Stock Exchange of India Ltd.
Financial Performance
The company delivered steady growth despite a challenging environment, driven by its two complementary business pillars: products and services. Over the last three years, QMS Medical has achieved an 18% revenue CAGR, a 32% EBITDA CAGR, and a 23% PAT CAGR.
| Metric | FY26 Value |
|---|---|
| Revenue from Operations | INR172.9 crores |
| EBITDA | INR25.9 crores |
| Profit After Tax | INR11.9 crores |
Business Segments
The product segment contributed approximately 69% of the total revenue, supported by a portfolio of over 900 SKUs. The services segment, which includes healthcare screening camps and patient engagement programs, contributed 31% of the revenue. During FY26, the company successfully conducted 32,380 healthcare camps across India. To strengthen its position in patient support programs, QMS Medical increased its stake in Saarathi Healthcare to 76%.
Future Outlook
Management remains optimistic about future opportunities, citing the shift towards patient-focused engagement in the healthcare sector. The company has invested in people, technology, and infrastructure to support long-term growth, particularly in patient service programs. These investments are expected to drive scalability and improve healthcare outcomes.
Historical Stock Returns for QMS Medical Allied Services
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +1.65% | +1.49% | +16.59% | +13.22% | +23.22% | -20.64% |
How will the increased stake in Saarathi Healthcare contribute to revenue growth in the next fiscal year?
What are the expected financial impacts of the recent investments in technology and infrastructure?
How does QMS Medical plan to expand its product portfolio beyond the current 900 SKUs?



























